Unilever states GSK customer arm ‘strong tactical fit’ for company

Unilever says GSK consumer arm 'strong strategic fit' for business

Revealed: The Secrets our Clients Used to Earn $3 Billion

A consumer picks bar of Dove soap, a Unilever item, at a Sainsbury’s grocery store in London, U.K.

Bloomberg|Getty Images

Dove soap maker Unilever signified on Monday it would pursue an offer for GlaxoSmithKline’s customer health company, calling it a “strong strategic fit” after its 50- billion-pound technique ($684 billion) was turned down.

The upgrade follows GSK verified over the weekend that it had actually turned down the Unilever deal for its customer health care company, which is house to brand names such as Sensodyne tooth paste and Emergen- C vitamin supplement.

“The acquisition would create scale and a growth platform for the combined portfolio in the U.S., China and India, with further opportunities in other emerging markets,” Unilever stated, indicating synergies in the oral care and vitamin supplements company.

Unilever held talks with banks about extra funding for a prospective sweetened deal for GSK’s customer items department, Bloomberg News reported on Sunday, pointing out individuals acquainted with the matter.

Unilever, which is set to reveal an effort later on this month to reinforce its company, stated on Monday it was devoted to “strict financial discipline” for any acquisitions.

This site uses Akismet to reduce spam. Learn how your comment data is processed.